John Cacciamani, MD, is stepping down from his role as president and CEO of  Philadelphia-based Chestnut Hill Hospital, part of Philadelphia-based Temple Health, effective immediately. Jeremy Slaga, chief integration officer at Temple Health, is stepping in as interim CEO while the hospital searches for a permanent CEO, according to a March 5 news release shared with Becker's.Rebecca Gubanich, vice president of finance, and Scott Friend, vice president and chief quality officer, are also stepping down from their roles at Chestnut Hill Hospital.Gerald Oetzel, chief financial officer of Temple Health, will take over Chestnut Hill Hospital's financial operations.Carl Sirio, MD, chief medical officer of Temple Health, will oversee the hospital's clinical quality and safety initiatives, infection prevention, clinical risk mitigation, and medical staff affairs and relations.

医学博士约翰·卡奇亚马尼（JohnCacciamani）即将辞去费城板栗山医院（Chestnut Hill Hospital）总裁兼首席执行官的职务，该医院是费城Temple Health的一部分，立即生效。根据3月5日与贝克尔共享的新闻稿，Temple Health首席整合官杰里米·斯拉加（JeremySlaga）将出任临时首席执行官，同时该医院正在寻找一位永久首席执行官。财务副总裁丽贝卡·古巴尼奇（RebeccaGubanich）和副总裁兼首席质量官斯科特·弗里德（ScottFriend）也将辞去他们在板栗山医院的职务。Temple Health首席财务官杰拉尔德·奥泽尔（GeraldOetzel）将接管板栗山医院的财务运营。Temple Health首席医疗官Carl Sirio医学博士将监督医院的临床质量和安全举措、感染预防、临床风险缓解以及医务人员事务和关系。

Dr. Sirio will work closely with James Helstrom, MD, the hospital's interim CMO and CMO of Philadelphia-based Fox Chase Cancer Center. .

Sirio博士将与James Helstrom医学博士、医院临时首席医学官和位于费城的福克斯蔡斯癌症中心首席医学官密切合作。。